Brief: Tianjin TEDA Biomedical Engineering Reports Quarterly Revenue From Cont Ops Of RMB92.8 Million
Nov 12 (Reuters) - Tianjin TEDA Biomedical Engineering Co
Ltd 8189.HK :
* QTRLY LOSS ATTRIBUTABLE RMB50.9 MILLION VERSUS LOSS OF
RMB7.1
MILLION
* QTRLY REVENUE FROM CONTINUING OPERATION RMB92.8 MILLION
VERSUS
RMB90.9 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6VHDg
Further company coverage: 8189.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Tianjin Teda Biomedical Engineering Co
See all newsBrief: Tianjin Teda Biomedical Engineering Appoints Lynn Li As Joint CEO, Re-Designates Sun Li As Joint CEO
Brief: Tianjin Teda Biomedical Engineering Signs AI Healthcare Cooperation Agreement
Brief: Tianjin Teda Biomedical Engineering Says Unit Enters Strategic Cooperation
Brief: Tianjin Teda Biomedical Engineering Says Zhongtai International Securities To Procure Placees
Brief: Tianjin Teda Biomedical Engineering Says Re-Designation Of He Xin To Non-Executive Director